Engitix Announces $54m Series A Financing and a Strategic Collaboration with Dompé Farmaceutici Using Exscalate’s AI Supercomputing Power to Advance its Drug Discovery Pipeline in Fibrosis and Cancer $54m series A financing co-led by existing investor Netherton Investments (a fund investing on behalf of  Mike Platt) and new investor Dompé farmaceutici S.P.A (an Italian and US-based biopharmaceutical company) … Continue reading Engitix secures £40 million Series A investment co-led by Netherton Investments and Dompé farmaceutici S.P.A